₹74.14
▼ -3.36 -4.34%
As of 22 Sept 2026 · delayed
BSE Listed
Novelix Pharmaceuticals Limited (536565)
Volume: 3,472Avg Vol 1W: 4,433Avg Vol 1M: 4,03952W Range:₹38₹92
Key Ratios
Checked 2h agoMarket Cap₹211 Cr
Current Price₹74.14
Previous Close₹77.5
High / Low (52w)₹92 / ₹38
Volume3,472
Avg Vol (1W)4,433
Avg Vol (1M)4,039
Stock P/E58.38
Book Value₹23.08
Dividend Yield0%
ROE5.5%
ROA391.69%
Revenue (TTM)—
Revenue Growth—
Profit Margin246.49%
Total Debt—
Shares Outstanding3 Cr
Face Value—
EPS (TTM)₹1.27
P/B3.21
Debt / Equity0.01
50 DMA₹74.68
200 DMA₹64.1
Day change-4.34%
Price Chart
₹74.14▲ 85.40% · 1Y
2025-09-222026-09-22
20-day avg volume: 4K shares
Pros
- Company is almost debt-free.
- Revenue grew 47% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 58.
Quarterly Results
| Metric | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹-3 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4 Cr | ₹5 Cr | ₹21 Cr | ₹22 Cr | ₹36 Cr | ₹48 Cr | ₹25 Cr | ₹37 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹13 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹10 Cr | ₹9 Cr |
| Total Liabilities | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| Equity | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹8 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-1 Cr | ₹2 Cr | ₹-2 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| Investing | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr |
| Free Cash Flow | ₹-1 Cr | ₹2 Cr | ₹-2 Cr | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
Shareholding
Promoter 54.29% Institutions 0% Public 45.71%
Efficiency & Working Capital
ROCE6.7%
Interest Coverage-33
Dividend Payout—
Debtor Days52 d
Inventory Days42 d
Payable Days37 d
Cash Conversion Cycle57 d
Working Capital Days94 d
Shareholding Details
As of 2026-07-31
Promoter54.3%
FII0%
DII0%
Institutions0%
Public45.7%
Promoter Pledge0%
No. of Shareholders3,127
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.6% | 66.6% | 52.7% | 53.3% | 54.8% | 54.8% | 52% | 50.8% | 46.5% | 49.4% | 50.6% | 54.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 33.4% | 33.4% | 47.3% | 46.7% | 45.2% | 45.2% | 48% | 49.2% | 53.5% | 50.6% | 49.4% | 45.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,502 | 2,484 | 2,408 | 2,754 | 2,770 | 2,770 | 2,994 | 2,997 | 3,029 | 2,975 | 3,118 | 3,127 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Srinidhi Fine-chemicals Llp | Shareholding of Promoter and Promoter Group | 35.1% | 1.00 Cr |
| Vupparapalli Chandrasekhar Reddy | Shareholding of Promoter and Promoter Group | 10.2% | 29,05,733 |
| Mallela Venkatramna Reddy | Public Shareholding | 6.4% | 18,30,000 |
| Narhari Belide | Shareholding of Promoter and Promoter Group | 4.2% | 12,00,000 |
| Sesha Sai Nikhil Chintalapati | Public Shareholding | 3.4% | 9,68,000 |
| Srinivasrao Swetha Kanakapur | Public Shareholding | 3.1% | 8,67,000 |
| Vupparapalli Pavani | Shareholding of Promoter and Promoter Group | 2.6% | 7,25,000 |
| Panchagnula Venkata Lakshmi Narayana Sankara Vara Prasad | Public Shareholding | 2.2% | 6,25,000 |
| Palakurthi Rakesh | Public Shareholding | 2% | 5,74,125 |
| Gattu Gnana Prakash | Shareholding of Promoter and Promoter Group | 1.4% | 4,00,000 |
| Arati Gattu | Shareholding of Promoter and Promoter Group | 0.4% | 1,00,000 |
| Neha Gattu | Shareholding of Promoter and Promoter Group | 0.4% | 1,00,000 |
| Shyam Agarwal (huf) | Shareholding of Promoter and Promoter Group | 0.1% | 25,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| VENKATESHWARLU PULLURU | E D & Wholetime Director | 2025 |
| JANARDHAN DAS KABRA | Independent Non Exe. Director | 2025 |
| Jivamohan Divakar Valluri | Non-Exec & Non-Independent Dir | 2025 |
| Monam Kapoor | Independent Non Exe. Director | 2025 |
| Lakshman Samala | Independent Non Exe. Director | 2025 |
| GNANA PRAKASH GATTU | Whole Time Director | 2025 |
| Mayuri Baidya | Independent Non Exe. Director | 2025 |
| Nishita Kalantri | Company Sec. & Compli. Officer | 2025 |
| Sridevi Belide | Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharma Business | ₹0 Cr | 3.2% |
| Financial Activity | ₹0 Cr | 4.5% |
| Investment Activity | ₹0 Cr | 1.5% |
| Trading in Shares | ₹4 Cr | 90.8% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 20 | 21 | 21 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-13 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
9 recent disclosure(s)
Neha GattuAcquisition · 1,00,000
VUPPARAPALLI CHANDRASEKHARAcquisition · 7,75,000
Narhari BelideAcquisition · 4,00,000
SRINIDHI FINE CHEMICALS LLPAcquisition · 21,00,000
Arati GattuAcquisition · 1,00,000
Gattu Gnana PrakashAcquisition · 50,000
Substantial Acquisitions (SAST)
7 disclosure(s)
Conv. of Warrants09/07/2026 · 7,75,000
Conv. of Warrants09/07/2026 · 21,00,000
Conv. of Warrants09/07/2026 · 1,00,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Pref. Allotment12/02/2026 · 3,25,000
Company Information
🌐 www.trimurthidrugs.com ↗
📍 4-4-231/1/2/ABC Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Money Masters Leasing & Finance Ltd.Alacrity Securities Ltd.GCM Commodity & Derivatives Ltd.Julien Agro Infratech LimitedJK Agri Genetics Ltd.Future Lifestyle FashionsPVV Infra LimitedVCU Data Management Ltd.IND Renewable Energy Ltd.SRG Fingrow Finance LimitedAmrapali Capital and Finance Services Ltd.Stellar Capital Services Ltd.All “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search